Clausine I exhibits significant biological activity, making it valuable in pharmaceutical and biomedical research. It has demonstrated anti-inflammatory and neuroprotective properties, which are useful in studying neurodegenerative conditions such as Alzheimer's and Parkinson’s disease. Its ability to modulate cellular signaling pathways also supports its potential in cancer research, particularly in inhibiting the growth of certain tumor cell lines. Additionally, Clausine I shows antimicrobial effects, suggesting possible use in developing new antimicrobial agents. Due to its natural origin and structural complexity, it serves as a lead compound for synthesizing derivatives with enhanced therapeutic effects.